Search Results - "Pollock, Richard F"

Refine Results
  1. 1

    Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant by Muduma, Gorden, Saunders, Rhodri, Odeyemi, Isaac, Pollock, Richard F

    Published in PloS one (03-11-2016)
    “…Several meta-analyses comparing ciclosporin with tacrolimus have been conducted since the 1994 publication of the tacrolimus registration trials, but most…”
    Get full text
    Journal Article
  2. 2

    Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs by Grabe-Heyne, Kristin, Henne, Christof, Mariappan, Paramananthan, Geiges, Götz, Pöhlmann, Johannes, Pollock, Richard F

    Published in Frontiers in oncology (02-06-2023)
    “…Bladder cancer ranks among the most common cancers globally. At diagnosis, 75% of patients have non-muscle-invasive bladder cancer (NMIBC). Patients with…”
    Get full text
    Journal Article
  3. 3

    Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO2 emissions in Sweden by Cardell, Lars-Olaf, Sterner, Thomas, Ahmed, Waqas, Slættanes, Andreas Kallsoy, Svärd, Mikael, Pollock, Richard F.

    Published in Scientific reports (18-01-2024)
    “…In Sweden, allergy immunotherapy (AIT) is available as either subcutaneous immunotherapy (SCIT) injections or sublingual immunotherapy (SLIT) tablets and is…”
    Get full text
    Journal Article
  4. 4

    High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma by Pöhlmann, Johannes, Weller, Michael, Marcellusi, Andrea, Grabe-Heyne, Kristin, Krott-Coi, Lucia, Rabar, Silvia, Pollock, Richard F

    Published in Frontiers in oncology (20-03-2024)
    “…Gliomas are a group of heterogeneous tumors that account for substantial morbidity, mortality, and costs to patients and healthcare systems globally. Survival…”
    Get full text
    Journal Article
  5. 5

    Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada by Alshannaq, Hamza, Isitt, John J, Pollock, Richard F, Norman, Gregory J, Cogswell, Greg, Lynch, Peter M, Roze, Stéphane

    “…Aim: Clinical trials and real-world data for Type 2 diabetes have shown that real-time continuous glucose monitoring (rt-CGM) lowers glycated hemoglobin (A1c)…”
    Get full text
    Journal Article
  6. 6

    Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France by Alshannaq, Hamza, Pollock, Richard F, Joubert, Michael, Ahmed, Waqas, Norman, Gregory J, Lynch, Peter M, Roze, Stéphane

    “…Clinical trials and real-world data for Type II diabetes both show that glycated hemoglobin (HbA1c) levels and hypoglycemia occurrence can be reduced by…”
    Get full text
    Journal Article
  7. 7

    ITULAZAX® versus Alutard SQ® in the treatment of allergic rhinitis induced by pollen from the birch homologous group: A cost‐minimization modeling analysis from the Danish societal perspective by Rønborg, Steen M., Grand, Tobias Sydendal, Brandi, Henrik, Pollock, Richard F.

    Published in Clinical and translational allergy (01-11-2022)
    “…Background and aims Allergic rhinitis (AR) is an inflammatory disorder triggered by an allergic immune response to inhaled allergens. Birch pollen is the major…”
    Get full text
    Journal Article
  8. 8

    The Prime Diabetes Model: Novel Methods for Estimating Long-Term Clinical and Cost Outcomes in Type 1 Diabetes Mellitus by Valentine, William J., PhD, Pollock, Richard F., MA, Saunders, Rhodri, PhD, Bae, Jay, PhD, Norrbacka, Kirsi, MSc, Boye, Kristina, PhD, MPH

    Published in Value in health (01-07-2017)
    “…Abstract Background Recent publications describing long-term follow-up from landmark trials and diabetes registries represent an opportunity to revisit…”
    Get full text
    Journal Article
  9. 9

    DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK by Pollock, Richard F., Valentine, William J., Marso, Steven P., Gundgaard, Jens, Hallén, Nino, Hansen, Lars L., Tutkunkardas, Deniz, Buse, John B.

    Published in Diabetes therapy (01-06-2018)
    “…Introduction The aim of this study was to evaluate the short-term cost-utility of insulin degludec (degludec) versus insulin glargine 100 units/mL (glargine…”
    Get full text
    Journal Article
  10. 10

    Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia by Pollock, Richard F, Biggar, Patrick

    Published in Expert review of hematology (01-02-2020)
    “…: The benefits of intravenous (IV) iron greatly outweigh the risks, but IV iron formulations carry a small risk of hypersensitivity reactions (HSRs). The…”
    Get more information
    Journal Article
  11. 11

    A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China by Zhang, Fengkui, Shen, Aizong, Ahmed, Waqas, Pollock, Richard F.

    Published in Advances in therapy (01-11-2024)
    “…Introduction Intravenous (IV) iron is the recommended treatment for patients with iron deficiency anemia (IDA) unresponsive to oral iron treatment, in whom…”
    Get full text
    Journal Article
  12. 12

    Incidence of Hypophosphatemia After Intravenous Administration of Iron: A Matching-Adjusted Indirect Comparison of Data from Japanese Randomized Controlled Trials by Fukumoto, Seiji, Murata, Tatsunori, Osuga, Yutaka, Pollock, Richard F.

    Published in Advances in therapy (01-11-2023)
    “…Introduction Intravenous (IV) administration of iron is considered a safe and efficacious treatment for iron deficiency anemia (IDA), recommended in patients…”
    Get full text
    Journal Article
  13. 13

    Association of adverse events and quality of life in patients with unresectable hepatocellular carcinoma by Agirrezabal, Ion, Pollock, Richard F, Carion, Phuong Lien, Shergill, Suki, Brennan, Victoria K, Pereira, Helena, Chatellier, Gilles, Vilgrain, Valérie

    Published in Quality of life research (16-10-2024)
    “…Hepatocellular carcinoma (HCC) is the third-leading cause of cancer-related deaths globally. Patients are often diagnosed with advanced disease, in which…”
    Get full text
    Journal Article
  14. 14

    A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom by Pollock, Richard F, Muduma, Gorden

    Published in Journal of medical economics (02-07-2020)
    “…Intravenous iron is the recommended treatment for patients with iron deficiency anemia (IDA) where oral iron is ineffective or rapid iron replenishment is…”
    Get more information
    Journal Article
  15. 15
  16. 16

    BioSAVE: display of scored annotation within a sequence context by Pollock, Richard F, Adryan, Boris

    Published in BMC bioinformatics (20-03-2008)
    “…Visualization of sequence annotation is a common feature in many bioinformatics tools. For many applications it is desirable to restrict the display of such…”
    Get full text
    Journal Article
  17. 17

    A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment by Pollock, Richard F, Muduma, Gorden

    Published in Expert review of hematology (01-02-2019)
    “…The efficacy of oral iron in treating iron deficiency anemia (IDA) can be limited by poor gastrointestinal (GI) absorption and adverse GI symptoms; intravenous…”
    Get more information
    Journal Article
  18. 18

    An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark by Pollock, Richard F., Muduma, Gorden

    Published in Advances in therapy (01-12-2018)
    “…Introduction The incidence of inflammatory bowel disease (IBD) in Denmark is among the highest in the world, with Crohn’s disease and ulcerative colitis…”
    Get full text
    Journal Article
  19. 19

    Long-acting insulin analogs: a review of "real-world" effectiveness in patients with type 2 diabetes by Pollock, Richard F, Erny-Albrecht, Katrina M, Kalsekar, Anupama, Bruhn, David, Valentine, William J

    Published in Current diabetes reviews (01-01-2011)
    “…A systematic review was conducted to evaluate the effectiveness of initiating insulin treatment with insulin glargine or insulin detemir for type 2 diabetes in…”
    Get more information
    Journal Article
  20. 20

    Development of a Resource Impact Model for Clinics Treating Pre-Operative Iron Deficiency Anemia in Ireland by Loughnane, Frank, Muduma, Gorden, Pollock, Richard F.

    Published in Advances in therapy (01-03-2020)
    “…Introduction Intravenous (IV) iron is typically the preferred treatment for patients with iron deficiency anemia (IDA) who cannot tolerate or absorb oral iron,…”
    Get full text
    Journal Article